Heather Hudson, DO
Psychiatry · Barberton, OHNPI 1902040256
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,725 of the $4,214 with a category attached, or 64.7%. Teladoc Health, Inc. accounts for 64.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,122 and has fallen 99.3% since, to $14 in 2025.
Across 108 payments — averaging $39.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teladoc Health, Inc.$3K
- Otsuka America Pharmaceutical, Inc.$347
- Sunovion Pharmaceuticals Inc.$294
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$258
- AbbVie$203
- Takeda Pharmaceuticals U.S.A., Inc.$132
- plus $255 from 6 others
What the payments were for
- Speaking & faculty fees$2,72565%
- Food & beverage$1,39833%
- Education$912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teladoc Health, Inc. | 5 | $2,725 |
| Otsuka America Pharmaceutical, Inc. | 27 | $347 |
| Sunovion Pharmaceuticals Inc. | 18 | $294 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $258 |
| AbbVie(2 entities) | 18 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $132 |
| Vanda Pharmaceuticals Inc. | 8 | $111 |
| Lundbeck LLC | 6 | $81 |
| Almatica Pharma LLC | 1 | $22 |
| Indivior Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $12 |
How this compares
$4,214 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 17 | $2,978 |
| Bupropion XlBupropion Hcl | 41 | $2,188 |
| Vilazodone Hcl | 13 | $2,061 |
| Buspirone Hcl | 26 | $946 |
| Bupropion Hcl SrBupropion Hcl | 20 | $840 |
| Hydroxyzine Hcl | 21 | $836 |
| Lamotrigine | 33 | $643 |
| Alprazolam | 32 | $564 |
| Quetiapine Fumarate | 27 | $555 |
| Duloxetine Hcl | 23 | $555 |
| Fluoxetine Hcl | 47 | $534 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $402 |
| Trazodone Hcl | 38 | $389 |
| Escitalopram Oxalate | 21 | $335 |
| Clonazepam | 25 | $308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $22 | $14714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Barberton
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
- Tracey SkaleCincinnati$674K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.